宣肺补益汤联合谷胱甘肽治疗慢性阻塞性肺疾病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:


Clinical Study on Xuanfei Buyi Decoction Combined with Glutathione for Chronic Obstructive Pulmonary Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察宣肺补益汤联合谷胱甘肽治疗慢性阻塞性肺疾病(COPD) 患者的临床效果。方法:将 100 例COPD 患者按照单双号法随机分为对照组与研究组各50 例,对照组采用常规治疗,研究组在对照组基 础上加用宣肺补益汤联合谷胱甘肽治疗。比较2 组治疗前后呼吸功能指标、炎性因子水平、6 min 步行试验变 化情况,并比较2 组临床疗效及不良反应发生情况。结果:治疗后,研究组总有效率98.00%,高于对照组 70.00%(P<0.05)。治疗前,2 组肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8) 水平 比较,差异无统计学意义(P>0.05);治疗后,2 组TNF-α、IL-6、IL-8 水平均降低,且研究组低于对照 组(P<0.05)。治疗前,2 组第1 秒用力呼气容积占预计值的百分比(FEV1%)、FEV1/用力肺活量(FVC) 比 较,差异无统计学意义(P>0.05);治疗后,2 组FEV1%、FEV1/FVC 均升高(P<0.05),且研究组高于对照 组(P<0.05)。治疗前,2 组6 min 步行试验距离比较,差异无统计学意义(P>0.05);治疗后,研究组6 min 步行试验距离延长(P<0.05),且研究组长于对照组(P<0.05)。研究组不良反应总发生率32.00%,低于对照 组56.00%(P<0.05)。结论:中药宣肺补益汤联合谷胱甘肽治疗COPD,可促进患者的血气状态恢复稳定,克 服疾病产生的氧化应激反应,同时促进患者呼吸功能的恢复,且安全性良好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Xuanfei Buyi Decoction combined with Glutathione for chronic obstructive pulmonary disease (COPD). Methods: A total of 100 cases of COPD patients were divided into the control group and the study group according to the odd- even number method,with 50 cases in each group. The control group was treated with routine treatment,and the study group was additionally treated with Xuanfei Buyi Decoction combined with Glutathione based on the treatment of the control group. The changes in respiratory function indexes, inflammatory factor levels, and 6- minute walking test (6MWT) before and after treatment, as well as the clinical effects and the incidence of adverse reactions,were compared between the two groups. Results:After treatment,the total effective rate was 98.00% in the study group,higher than that of 70.00% in the control group (P< 0.05). Before treatment,there was no significant difference being found in the comparison of the levels of tumor necrosis factor-α (TNF-α),interleukin-6 (IL-6),and interleukin-8 (IL-8) between the two groups (P>0.05). After treatment,the levels of TNF-α,IL-6,and IL-8 in the two groups were decreased when compared with those before treatment,and the three levels in the study group were lower than those in the control group (P<0.05). Before treatment, there was no significant difference being found in the comparison of the forced expiratory volume in one second predicted (FEV1%) and FEV1/forced vital capacity (FVC) between the two groups (P>0.05). After treatment,FEV1% and FEV1/FVC in the two groups were increased when compared with those before treatment (P<0.05),and the two indexes in the study group were higher than those in the control group (P<0.05). Before treatment, no significant difference was found in the comparison of the 6MWT distance between the two groups (P>0.05). After treatment, the 6MWT distance in the two groups was prolonged when compared with that before treatment (P<0.05), and the distance in the study group was longer than that in the control group (P<0.05). The total incidence of adverse reactions was 32.00% in the study group,lower than that of 56.00% in the control group (P< 0.05). Conclusion: Xuanfei Buyi Decoction combined with Glutathione for COPD can promote the stable recovery of the blood gas and the recovery of respiratory function of patients, and help overcome the oxidative stress reactions caused by the disease,with good safety.

    参考文献
    相似文献
    引证文献
引用本文

水昳,张霆.宣肺补益汤联合谷胱甘肽治疗慢性阻塞性肺疾病临床研究[J].新中医,2023,55(7):111-114

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-12
  • 出版日期:
文章二维码